By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aurinia (Formerly Known as Isotechnika Pharma Inc.) 

5120 - 75th Street

Edmonton  Alberta  T6E 6W2  Canada
Phone: 780-487-1600 Fax: 780-484-4105


SEARCH JOBS


Key Statistics


Email:
Ownership: Public

Web Site: Aurinia
Employees:
Symbol: AUPH
 









Company News
Aurinia (AUPH) Announces Results Of Annual General Meeting 6/23/2017 6:12:45 AM
Aurinia (AUPH) To Host Annual General Meeting Of Shareholders And Webcast On June 21 In Vancouver, BC 6/21/2017 6:33:07 AM
Aurinia (AUPH) Release: Voclosporin Remission Data From The Phase IIb AURA-LV Study Highlighted At EULAR 2017 6/16/2017 7:28:53 AM
Aurinia (AUPH) Presents Additional Data From Phase IIb AURA-LV Study, Demonstrating Stable Renal Function And Blood Pressure Without Electrolyte Complications Through 48 Weeks 6/5/2017 12:39:26 PM
Aurinia (AUPH) To Participate In Late Breaking Oral Presentations At Two Upcoming Scientific Conferences 5/31/2017 6:45:14 AM
Aurinia (AUPH) Doses First Patient In AURORA Phase III Clinical Trial Of Voclosporin In Lupus Nephritis 5/18/2017 9:00:15 AM
Aurinia (AUPH) Reports First Quarter 2017 Financial Results, Announces Initiation Of Phase III Aurora Clinical Trial, And Provides Operational Highlights 5/15/2017 8:52:10 AM
Pharma Industry Veteran Dr. George Milne Joins Aurinia (AUPH)’s Board Of Directors 5/9/2017 9:33:01 AM
Aurinia (AUPH) Releases Additional 48-Week Data From The AURA-LV Study During Late-Breaking Session At National Kidney Foundation 2017 Spring Clinical Meetings 4/21/2017 6:15:35 AM
Aurinia (AUPH) Completes Licensing Deal With Merck Animal Health For Its Nanomicellar Formulation Of Voclosporin For The Treatment Of Canine Dry Eye Syndrome 4/18/2017 7:11:59 AM
12345678910...
//-->